The Burden of Steatotic Liver Disease Before and During the COVID-19 Pandemic: Correspondence to Editorial on “Current Burden of Steatotic Liver Disease and Fibrosis Among Adults in the United States, 2017–2023”

Authors

Donghee Kim
Pojsakorn Danpanichkul
Karn Wijarnpreecha
George Cholankeril
Rohit Loomba
Aijaz Ahmed

Language

English

Publication Date

4-1-2025

Journal

Clinical and Molecular Hepatology

DOI

10.3350/cmh.2025.0152

PMID

39957373

PMCID

PMC12016646

PubMedCentral® Posted Date

2-17-2025

PubMedCentral® Full Text Version

Post-print

Keywords

COVID-19, MASLD, NAFLD, SLD

Published Open-Access

yes

Recommended Citation

Kim, Donghee; Danpanichkul, Pojsakorn; Wijarnpreecha, Karn; et al., "The Burden of Steatotic Liver Disease Before and During the COVID-19 Pandemic: Correspondence to Editorial on “Current Burden of Steatotic Liver Disease and Fibrosis Among Adults in the United States, 2017–2023”" (2025). Faculty and Staff Publications. 4433.
https://digitalcommons.library.tmc.edu/baylor_docs/4433